NCT04494880

Marcaine Post-Operative Pain Study

• Status: Completed
• Phase: EARLY_Phase 1
• Study type: Interventional
• Enrollment: 22 (actual)
• Sponsor: State University of New York - Upstate Medical University · Academic / Other
• Sex: All
• Age: 89 Years
• Healthy volunteers: Accepted

Summary

The study examines the efficacy of Marcaine in post-operative pain reduction for patients receiving breast reduction surgery. Patients who consent will be randomized to which breast receives a Marcaine injection and the other breast will have saline injected. Pain will be assessed one time post-operatively using a 1-10 pain scale.

Conditions

• Effect of Drug

Interventions

Type	Name	Description
DRUG	Bupivacaine Injection	Treatment group receives Marcaine (Bupivacaine) injected into one breast following breast reduction surgery and a saline injection in the other group.

Timeline

• Start date: 2020-12-09
• Primary completion: 2022-12-01
• Completion: 2022-12-31
• First posted: 2020-07-31
• Last updated: 2023-12-15

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study